Cancer Diagnostics – Multimedia

This article explores how cell-to-cell communication can be targeted for novel treatment methods.

Liquid biopsies are a minimally invasive alternative that can detect the presence of circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) as tumor biomarkers.

This whitepaper demonstrates how common methylation detection methods can be combined with Droplet Digital PCR (ddPCR) to enhance the cfDNA analysis for clinical and research applications.

This poster describes an optimized target enrichment protocol designed to enhance the capture and conversion of fragmented cfDNA for reliable NGS.

This case study presents a scalable, automation-friendly workflow for active deparaffinization, extraction and purification of nucleic acids from FFPE samples that can transform cancer diagnostics as demand grows.

This app note highlights a robust targeted RNA enrichment workflow that integrates automation to expedite library preparation and data analysis.

Automated cell imaging and picking systems can unlock the full potential of CTCs, with rapid, automated and highly accurate methods for isolation, enrichment and identification.

This poster highlights how this technology can provide accurate detection of genetic variants and variant-associated methylation in colorectal cancer samples.

In this episode we speak with Tom Charlesworth and discuss how the 6-base genome can improve the understanding tumour biology from liquid biopsy.

Learn what truly matters in cfDNA quality analysis. The Agilent Cell-free ScreenTape assay for the Agilent TapeStation systems uses the %cfDNA score to characterize HMW contamination and provides the actual cfDNA concentration.